Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug

被引：0
|
作者：
Tanaka, Yuya [1 ]
Kobayashi, Takehiko [2 ]
Shimizu, Shigeki [3 ]
Kurahara, Yu [1 ,2 ,4 ]
机构：
[1] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Internal Med, Sakai, Japan
[2] Natl Hosp Org Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Japan
[3] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Pathol, Sakai, Japan
[4] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Infect Dis, Sakai, Japan
来源：
INTERNAL MEDICINE | 2024年 / 63卷 / 18期
关键词：
cutaneous leukocytoclastic vasculitis; pulmonary tuberculosis;
D O I：
10.2169/internalmedicine.3144-23
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：2587 / 2588
页数：2
相关论文
共 50 条
  • [21] Two cases of leukocytoclastic vasculitis with tuberculosis
    Lee, AY
    Jang, JH
    Lee, KH
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1998, 23 (05) : 225 - 226
  • [22] Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions
    Lehloenya, R. J.
    Todd, G.
    Badri, M.
    Dheda, K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (12) : 1649 - 1655
  • [23] Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future
    Lehloenya, Rannakoe J.
    Dheda, Keertan
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (04) : 475 - 486
  • [24] Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis
    Abbadi, Said H.
    Sameaa, G. Abdel
    Morlock, G.
    Cooksey, R. C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (06) : 673 - 678
  • [25] Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin
    Affolabi, D.
    Adjagba, O. A. B. G.
    Tanimomo-Kledjo, B.
    Gninafon, M.
    Anagonou, S. Y.
    Portaels, F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (11) : 1221 - 1224
  • [26] Retinal vasculitis associated with cutaneous leukocytoclastic vasculitis
    Basu, Soumyava
    Mittal, Ruchi
    INTERNATIONAL OPHTHALMOLOGY, 2019, 39 (02) : 451 - 453
  • [27] Tuberculosis Clinical Trial Update and the Current Anti-Tuberculosis Drug Portfolio
    Palomino, Juan Carlos
    Martin, Anandi
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (30) : 3785 - 3796
  • [28] Retinal vasculitis associated with cutaneous leukocytoclastic vasculitis
    Soumyava Basu
    Ruchi Mittal
    International Ophthalmology, 2019, 39 : 451 - 453
  • [29] Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs
    Shokouhi, Shervin
    Darazam, Ilad Alavi
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2015, 3 (01):
  • [30] Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus
    Kumar, A. K. Hemanth
    Chandrasekaran, V.
    Kannan, T.
    Murali, A. Lakshmi
    Lavanya, J.
    Sudha, V.
    Swaminathan, Soumya
    Ramachandran, Geetha
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (01) : 65 - 70
12345